reported that blocking TLR2/TLR4 in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis prevents the production of proinflammatory factors, which is consistent with our clinical data (26). This evidence concerns the gene TLR4 and multiple sclerosis.